News

Antiangiogenic Drugs Are Stopping Neovascularization in Wet Macular Degeneration

(Updated 3/12/22) A substance in the body called Vascular Endothelial Growth Factor (VEGF) is responsible for the growth of new blood vessels. It promotes this growth by stimulating the endothelial cells, which form the walls of the vessels and transport nutrients and oxygen to the tissues. Evidence shows that when the retinal pigment epithelial (RPE) [Read More]

Nutritional Risk Factors for AMD

by Dan Roberts August 1, 2012 (Reviewed by Jeffrey Anshel, O.D., F.A.A.O. (CEO, Ocular Nutrition Society) Risk factors for developing age-related macular degeneration (AMD) can be genetic, environmental, behavioral, or nutritional. This is a list of nutritional factors that have been linked to development of retinal dystrophies. High dosages of aspirin High caloric intake High [Read More]

Implantable Miniature Telescope (IMT) For AMD and Stargardt's Disease

by Dan Roberts (Updated: June 5, 2012) The IMT is a micro-sized precision telescope, about the size of a pea, that is implanted in one eye in an outpatient surgical procedure conducted under local anesthesia. The IMT provides magnification of 3.0X or 2.2X, depending on the IMT model used. A magnified image is projected over [Read More]

Summary of Research and Developments in Macular Degeneration, 2011-2012

by Dan Roberts June 2012 Introduction Here is MD Support’s summary of the the past twelve months of significant research and development in the field of macular degeneration. We begin with the field that has been making the most news: pharmacology. _______________________________ PHARMACOLOGY SEP: Infection Risk From Repackaged Avastin The big pharmaceutical news of the [Read More]